SCHEMBL20816293

SCHEMBL20816293

CNc1cc(-c2cccnc2)ncn1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 13/20 0.62
CYP3A4 P08684 13/20 0.62
CLK4 Q9HAZ1 11/20 0.62
HSD17B10 Q99714 10/20 0.62
CYP2D6 P10635 8/20 0.62
ALDH1A1 P00352 6/20 0.62
CYP2C19 P33261 8/20 0.59
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
KDM4E B2RXH2 2/20 0.59
HPGD P15428 2/20 0.59
TSHR P16473 3/20 0.57
ALOX15 P16050 6/20 0.56
KMO O15229 1/20 0.55
CYP2A6 P11509 4/20 0.53
TP53 P04637 2/20 0.49
PIM1 P11309 1/20 0.49
MAPK1 P28482 1/20 0.49
ABL1 P00519 1/20 0.48
BCR P11274 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20816281 0.81 CYP1A2 (0.62) CYP1A2CYP3A4CLK4HSD17B10CYP2D6
SCHEMBL12907691 0.80 CYP3A4 (0.58) CYP1A2CYP3A4CLK4HSD17B10CYP2D6
SCHEMBL20816285 0.80 ABL1 (0.55) CYP1A2CYP3A4CLK4HSD17B10CYP2D6
SCHEMBL19905207 0.79 CYP1A2 (0.51) CYP1A2CYP3A4CLK4HSD17B10CYP2D6
SCHEMBL6844957 0.78 CYP2A6 (0.62) CYP1A2CYP3A4CLK4HSD17B10CYP2D6
SCHEMBL18905235 0.78 KMO (0.68) CYP1A2CYP3A4CLK4HSD17B10CYP2D6
SCHEMBL30200067 0.77 CYP1A2 (0.54) CYP1A2CYP3A4CLK4HSD17B10CYP2D6
SCHEMBL3565337 0.76 ABL1 (0.66) CYP1A2CYP3A4CLK4HSD17B10CYP2D6
SCHEMBL28152165 0.75 HSP90AA1 (0.54) MEN1KMT2ATSHRCYP2A6PIM1
SCHEMBL24151512 0.75 KMO (0.59) CYP1A2CYP3A4CLK4HSD17B10CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10624897-B2 Chlorobenzene substituted azaaryl compounds TAIPEI MEDICAL UNIVERSITY (TW) 2020-04-21 US disclosed
US-10624897-B2 Chlorobenzene substituted azaaryl compounds TAIPEI MEDICAL UNIVERSITY (TW) 2020-04-21 US disclosed
US-20190083499-A1 CHLOROBENZENE SUBSTITUTED AZAARYL COMPOUNDS TAIPEI MEDICAL UNIVERSITY (TW) 2019-03-21 US disclosed
US-20190083499-A1 CHLOROBENZENE SUBSTITUTED AZAARYL COMPOUNDS TAIPEI MEDICAL UNIVERSITY (TW) 2019-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10624897-B2 Chlorobenzene substituted azaaryl compounds MKI67, CTCF, CDKN1A CYP1A2 95/4885CYP3A4 181/4885CLK4 2558/4885
US-20190083499-A1 CHLOROBENZENE SUBSTITUTED AZAARYL COMPOUNDS MKI67, CTCF, CDKN1A CYP1A2 95/4885CYP3A4 181/4885CLK4 2558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.